|
According to the reporter, during the dialysis treatment, blood leaked at the junction of the venous luer adapter and the silicone extension tube.The catheter was not repaired and normal saline was the cleaning agent used on the device.Tego was not utilized and there was no luer adapter issue.The insertion site was treated with normal saline and iodophor cotton balls.There was nothing unusual observed on the device prior to use.Flushing was done and no abnormality was found.From the time the catheter was implanted (implanted a day before the event) up to the time the issue occurred, the clamp was moved periodically.There were no other products utilized with the device and it had a tiny hole where the leak was observed.There was no excessive for used on the product.There was no blood loss and the product was replaced with a new one on the same day of the event.There was no patient injury.
|
|
Additional information: d9, g1 (mfr contact first name, last name, email, phone number), g3, h3, h6 h3 evaluation summary: medtronic conducted an investigation based upon all information received.The device was available for evaluation.Visual inspection noted a hole at the junction of the extension tube and blue luer adapter.It was reported that there was a hole on the extension tube.The reported issue was confirmed.The product analysis noted evidence that the device was not used as intended.This issue may occur when clamping the extension tube close to the luer adapter that causes excess stress on the extension tubing which can lead to breaks/leaks in the tubing where it connects to the luer adapter.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.The instructions included with this device provide the following guidance: clamping repeatedly on the same spot could weaken the tubing and clamping near the adapter and hub should be avoided.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|